SECURITY HOLDERS AGREEMENTSecurity Holders Agreement • July 12th, 2007 • ACCBT Corp. • Biological products, (no disgnostic substances)
THIS SECURITY HOLDERS AGREEMENT (“Agreement”), dated as of ____ ____, and among ACCBT Corp., a corporation duly incorporated under the laws of the British Virgin Islands (“ACCBT”), and the persons listed in Exhibit A (“Holders”). Each of ACCBT and the Holders is referred to herein as a “Party” and collectively as the “Parties”.
SUBSCRIPTION AGREEMENTSubscription Agreement • July 12th, 2007 • ACCBT Corp. • Biological products, (no disgnostic substances)
SUBSCRIPTION AGREEMENT (“Agreement”), dated as of July 2, 2007, by and between ACCBT Corp., a corporation duly incorporated under the laws of the British Virgin Islands (“ACCBT”), and Brainstorm Cell Therapeutics Inc., a corporation duly incorporated under the laws of the State of Delaware, USA (“Company”).
JOINT FILING OF SCHEDULE 13DJoint Filing Agreement • July 12th, 2007 • ACCBT Corp. • Biological products, (no disgnostic substances)
The undersigned hereby consent to the joint filing by any of them of a Statement on Schedule 13D and any amendments thereto, whether heretofore or hereafter filed, relating to the securities of Brainstorm Cell Therapeutics Inc., and affirm that this Schedule 13D is being filed on behalf of each of the undersigned. This agreement may be executed in one or more counterparts, each of which will be deemed an original, but all of which together shall constitute one and the same instrument.
ACCBT Corp. August 1, 2007Registration Rights Agreement • August 23rd, 2007 • ACCBT Corp. • Biological products, (no disgnostic substances)
The undersigned hereby agrees to be bound by and subject to the terms and conditions of the Second Restated and Amended Registration Rights Agreement between Ramot at Tel Aviv University Ltd. and Brainstorm Cell Therapeutics Inc. (the "Company"), dated August 1 2007, in connection with the Warrant issued by the Company dated August 1 2007, reflecting a right to receive 3,181,925 shares of Common Stock of the Company and in connection with the shares of Common stock issuable upon exercise of such Warrant.
